Skip to content
M&A

Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics for $32M

Published on · Source: investing.com

#ADIL#M&A
Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics for $32M

AI Summary

Summarized by AI from the source below

Adial Pharmaceuticals (ADIL) has acquired Azora Therapeutics for $32 million. This transaction is significant as it may broaden ADIL's portfolio and enhance its market presence. The deal could potentially impact ADIL's stock performance depending on the synergies and future revenues generated from Azora. Investors will be watching closely for any updates regarding the integration of the newly acquired assets.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Share:
Source: Read the original at investing.com (opens in new tab)

Get the weekly market brief

One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.

Get stories like this as they break

Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.

Join on TelegramFollow on X

Related News

Private Equity-Backed CEOs Face Shifting Challenges Amid Market Changes
M&A

Private Equity-Backed CEOs Face Shifting Challenges Amid Market Changes

Oct 27

Chinese Automakers Establish Mexico as First North America Base
M&A

Chinese Automakers Establish Mexico as First North America Base

Oct 27

3E Network (3EN) Announces $5 Million Private Placement Allocation Plan
M&A

3E Network (3EN) Announces $5 Million Private Placement Allocation Plan

Oct 27

Advent Raises $30 Billion for Latest Buyout and Mid-Market Funds
M&A

Advent Raises $30 Billion for Latest Buyout and Mid-Market Funds

Oct 27